Summary
STEP-1 through STEP-8 — trial designs, populations, primary endpoints. STEP-1 (NEJM 2021): 14.9% weight loss at 68 weeks. PMID 33567185. STEP-3, STEP-4, STEP-5 maintenance and adolescent data.
Source hierarchy
- Peer-reviewed publications in NEJM, Lancet, JAMA, Diabetes Care
- FDA prescribing information and label updates
- Clinicaltrials.gov registered trial protocols
- USP <797>, <71>, <85> pharmacy quality standards
Related clinical pages
Note for patients: Clinical trial data on this site is summarized for general education. Specific dosing decisions, contraindication assessments, and treatment plans must be made with a licensed healthcare provider who has reviewed your full medical history.
